HopeStage
Back to all studies
Not Yet RecruitingNCT07435077

Buprenorphine Versus Oxycodone for Addiction

Medication studyAges 18–80United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
Winston-SalemSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: March 2027
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
282
Sponsor
Wake Forest University Health Sciences
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT07435077
Official title
Show the full official title

Examining Analgesic Synergy and Efficacy in Trauma Care-A Randomized, Control Study of Buprenorphine Versus Oxycodone in Multimodal Pain Control Regimens

Recruitment & locations

Not yet recruiting

Winston-Salem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wake Forest University Health Sciences, a university.

Does this study involve medication?

Yes. The study involves medication, including Buprenorphine and Oxycodone.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies